Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

NCT00617929 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Replaced by another protocol

Conditions

Cancer

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: rituximab
DRUG: clofarabine
PROCEDURE: stem cell transplantation

Sponsor

Masonic Cancer Center, University of Minnesota